Hudson Bay Capital Management »

Fate Therapeutics shares owned by Hudson Bay Capital Management

Quarter-by-quarter ownership of Fate Therapeutics (FATE) shares owned by Hudson Bay Capital Management from 13F filings

Historical chart of Hudson Bay Capital Management investment in Fate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fate Therapeutics held by Hudson Bay Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fate Therapeutics by Hudson Bay Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $3.4M 460k 7.34
2022-12-31 $522k 52k 10.09

More positions owned by Hudson Bay Capital Management

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Microsoft Corporation Put Option (MSFT)
NVIDIA Corporation Call Option (NVDA)
Amazon Call Option (AMZN)
Apple Put Option (AAPL)
Alphabet Cap Stk Cl C Put Option (GOOG)
Meta Platforms Cl A Put Option (META)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Tesla Motors Put Option (TSLA)
Advanced Micro Devices Put Option (AMD)
Ishares Tr Msci Acwi Etf Put Option (ACWI)
Berkshire Hathaway Inc Del Cl B New Put Option (BRK.B)
Alphabet Cap Stk Cl A Put Option (GOOGL)
Pioneer Natural Resources Put Option (PXD)
Royal Caribbean Group Note 6.000% 8/1 (Principal)

View all positions for Hudson Bay Capital Management

Top funds holding Fate Therapeutics

Redmile Group
Vanguard Group
BlackRock
Boxer Capital
State Street Corporation
Deep Track Capital
Bellevue Group
Johnson & Johnson
Citadel Advisors
Morgan Stanley
D. E. Shaw & Co
Suvretta Capital Management
Assenagon Asset Management
Holocene Advisors
Deerfield Management Company

View all funds holding Fate Therapeutics